Ereksiyon Fonksiyon Bozukluğu (EFB) Tedavisinde Kullanılan Düşük Yoğunluklu Ekstrakorporeal Şok Dalga Terapisi (EŞDT) ile Yapılan Deneysel Çalışmalar ve Sonuçları
Özet
Ereksiyon fonksiyon bozukluğu (EFB), özellikle orta yaş ve üzeri erkeklerde yaşam kalitesini düşüren, vasküler, nöral ve hormonal faktörlere bağlı yaygın bir rahatsızlıktır. Mevcut tedaviler (PDE5i, intrakavernozal enjeksiyonlar, penil protez vb.) geçici çözümler sunmakta ve hastalığın altındaki temel patolojiyi düzeltememektedir. Bu bağlamda, Düşük Yoğunluklu Ekstrakorporeal Şok Dalga Terapisi (EŞDT / Li-ESWT), kalıcı ve kür sağlayan minimal invaziv bir alternatif olarak öne çıkmaktadır. Deneysel çalışmalar, EŞDT'nin erken dönemde nNOS ve eNOS aktivitesini artırarak nitrik oksit yapımını ve kan akışını uyardığını göstermektedir. Orta ve uzun dönemde ise vazoaktif endotelyal büyüme faktörlerini (VEGF) ve kök hücreleri aktive ederek yeni damar oluşumunu (neoanjiyogenez) tetikler. Ayrıca nNOS pozitif sinir liflerini onararak nöral rejenerasyon sağlar, BDNF uyarımı ile sinir hasarlarını iyileştirir ve radikal prostatektomi sonrası impotans için umut vadeder. Kavernozal dokudaki fibrotik değişimleri (skarlaşmayı) engelleyerek dokuyu yeniden yapılandırır. Son olarak, alfa-2 adrenerjik reseptör lehine değişim yaratarak sempatik tonusu azaltır ve performans anksiyetesine bağlı EFB'de de etkili olabileceğini gösterir. Sonuç olarak preklinik çalışmalar, EŞDT'nin yaşlanma, diyabet veya cerrahi hasar kaynaklı patolojileri hücresel düzeyde onardığını kanıtlamaktadır.
Erectile dysfunction (ED) is a common disorder linked to vascular, neural, and hormonal factors that significantly impairs the quality of life, particularly in middle-aged and older men, and while current treatments like PDE5 inhibitors, intracavernosal injections, or penile prostheses offer temporary solutions, they fail to correct the underlying pathology, which positions Low-Intensity Extracorporeal Shock Wave Therapy (Li-ESWT) as a promising, non-invasive, curative alternative; in fact, pre-clinical studies demonstrate that Li-ESWT stimulates nitric oxide production and blood flow in the short term by upregulating nNOS and eNOS activity, while in the medium-to-long term, it triggers neoangiogenesis by activating vasoactive endothelial growth factors (VEGF) and recruiting progenitor stem cells, induces neural regeneration and repair through BDNF stimulation—offering potential for post-prostatectomy impotence—and exerts antifibrotic effects that remodel cavernosal tissue to prevent aging-related scarring, furthermore, it modulates sympathetic tone by shifting the alpha-1/alpha-2 adrenergic receptor ratio in favor of alpha-2 receptors to alleviate performance anxiety, ultimately proving that shockwave therapy effectively repairs arterial, neural, and fibrotic tissue damage caused by aging, diabetes, or surgical trauma at a cellular level.
Referanslar
Kloner RA. Erectile dysfunction and cardiovascular risk factors. The Urologic clinics of North America. Nov 2005;32(4):397–402. https://doi.org10.1016/j.ucl.2005.08.005.
Eardley I. The Incidence, Prevalence, and Natural History of Erectile Dysfunction. Sexual Medicine Reviews. 2013 May;1(1):3-16. doi: 10,1002/smrj.2. Epub 2015 Oct 21. PMID: 27.784.558.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. The Journal of Urology. 1994 Jan;151(1):54-61. doi: 10,1016/s0022-5347(17)34871-1. PMID: 8254833.
Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. International Journal of Impotence Research. 2000 Dec;12(6):305-11. doi: 10,1038/sj. ijir.3900622. PMID: 11.416.833.
Johannes, C.B., et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. The Journal of Urology, 2000. 163: 460.
Capogrosso, P. et al. One patient out of four with newly diagnosed erectile dysfunction is a young man--worrisome picture from the everyday clinical practice. The Journal of Sexual Medicine, 2013. 10: 1833.
Grover SA, Lowensteyn I, Kaouache M, et al. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Archives of Internal Medicine 2006;166:213.
Sasayma S, Ishii N, Ishikura F, et al. Men’s health study: epidemiology of erectile dysfunction and cardiovascular disease. Circulation Journal 2003;67:656.
Kloner RA. Erectile dysfunction in the cardiac patient. Current Urology Reports 2003;4:466.
Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.The Journal of Urology 1994;151:54–61.
Gabrielson AT, Sartor RA, Hellstrom WJG. The impact of thyroid disease on sexual dysfunction in men and women. Sexual Medicine Reviews 2019;7(1):57–70.
Saigal CS, Wessells H, Pace J, et al. Predictors and prevalence of erectile dysfunction in a racially diverse population. Archives of Internal Medicine 2006;166:207.
Bacon C, Mittleman M, Kawachi I, et al. A prospective study of risk factors for erectile dysfunction.The Journal of Urology 2006;176:217.
Mulhall J, Goldstein I, Bushmakin A, et al. Validation of the erection hardness score. The Journal of Sexual Medicine 2007;4:1626.
Rosen R, Cappelleri JC, Smith M, et al. Development and evaluation of an abridged, 5- item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. International Journal of Impotence Research 1999;11.319.
Yuan J, Zhang R, Yang Z, Lee J, Liu Y, Tian J, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. European Urology 2013; 63.902-12.
Vardi Y, Appel B, Krichevsky A, et al. Does low-intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham-controlled study. The Journal of Urology 2012; 187:1769-1775.
Vardi Y, Appel B, Jacob G, Massarwi O, Gruenwald I. Can low-intensity extracorporeal shockwave therapy improve erectile function? A 6-month follow-up pilot study in patients with organic erectile dysfunction. European Urology. Aug 2010;58(2):243–8. https://doi.org10.1016/j.eururo.2010.04.004
Chaussy C, Schmiedt E, Brendel W. Extracorporeally induced distruction of kidney stones by shock waves. Lancet 1980; 2,1268.
Chaussy C, Schmiedt E, Jocham D, et al. First clinical experiences with extracorporeally induced destruction of kidney stones by shock waves. The Journal of Urology 1982;127:417-42.
Wang C-J. Extracorporeal shockwave therapy in musculoskeletal disorders. Journal of Orthopaedic Surgery and Research 2012; 7.11.
Gruenwald I, Appel B, Vardi Y. Low-intensity extracorporeal shock wave therapy–a novel effective treatment for erectile dysfunction in severe ED patients who respond poorly to PDE5 inhibitor therapy. The Journal of Sexual Medicine 2012; 9:259-264.
Sokolakis I, Dimitriadis F, Teo P, et al. The basic science behind low-intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic scoping review of pre-clinical studies. The Journal of Sexual Medicine 2019; 16:168-194.
Li H, Matheu MP, Sun F, et al. Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model. The Journal of Sexual Medicine 2016;13:22-32.
Qiu X, Lin G, Xin Z, et al. Effects of low-energy shockwave therapy on the erectile function and tissue of a diabetic rat model. The Journal of Sexual Medicine 2013;10:738-746.
Lin G, Reed-Maldonado AB, Wang B, et al. In situ activation of penile progenitor cells with low-intensity extracorporeal shockwave therapy. The Journal of Sexual Medicine 2017;14:493-501.
Wang B, Ning H, Reed-Maldonado AB, et al. Low intensity extracorporeal shock wave therapy enhances brain-derived neurotrophic factor expression through PERK/ATF4 signaling pathway. International Journal of Molecular Sciences.2017;18.433
Wang HS, Ruan Y, Banie L, et al. Delayed low-intensity extracorporeal shock wave therapy ameliorates impaired penile hemodynamics in rats subjected to pelvic neurovascular injury. The Journal of Sexual Medicine 2019;16:17-26.
Sokolakis I, Dimitriadis F, Psalla D, et al. Effects of lowintensity shock wave therapy (LiST) on the erectile tissue of naturally aged rats. International Journal of Impotence Research 2019;31.162-169.
